Table 2.
Men | ||||||
---|---|---|---|---|---|---|
Models | Quartile 1 0.41–2.43† (n = 176) |
Quartile 2 2.44–3.55† (n = 174) |
Quartile 3 3.56–5.64† (n = 168) |
Quartile 4 5.66–57.31† (n = 132) |
p-value* | |
LAD, mm | Age-adjusted | 30 | 32 | 32 | 33 | <0.0001 |
MV-adjusted | 31 | 32 | 32 | 31 | 0.42 | |
LVM/ht2.7, g/m2.7 | Age-adjusted | 27.1 | 27.5 | 27.9 | 29.7 | <0.0001 |
MV-adjusted | 28.8 | 28.0 | 27.3 | 27.6 | 0.01 | |
LVM/LVEDV gm/ml | Age-adjusted | 0.85 | 0.89 | 0.89 | 0.97 | <0.0001 |
MV-adjusted | 0.87 | 0.89 | 0.88 | 0.94 | 0.003 | |
RWT | Age-adjusted | 0.27 | 0.29 | 0.28 | 0.30 | 0.0004 |
MV-adjusted | 0.28 | 0.29 | 0.28 | 0.29 | 0.20 | |
CO, L/min | Age-adjusted | 5.7 | 5.8 | 6.0 | 6.1 | 0.003 |
MV-adjusted | 6.0 | 5.9 | 5.9 | 5.6 | 0.17 | |
LVEF (%) | Age-adjusted | 64 | 66 | 66 | 67 | 0.0003 |
MV-adjusted | 65 | 66 | 66 | 67 | 0.009 | |
Women | ||||||
Models |
Quartile 1 0.23–2.03† (n = 216) |
Quartile 2 2.04–2.84† (n = 213) |
Quartile 3 2.85–4.25† (n = 208) |
Quartile 4 4.26–43.01† (n = 175) |
p-value* | |
LAD, mm | Age-adjusted | 27 | 28 | 28 | 30 | <0.0001 |
MV-adjusted | 29 | 28 | 28 | 28 | 0.17 | |
LVM/ht2.7, g/m2.7 | Age-adjusted | 22.6 | 22.7 | 23.4 | 25.6 | <0.0001 |
MV-adjusted | 24.1 | 23.3 | 23.2 | 23.2 | 0.03 | |
LVM/LVEDV gm/ml | Age-adjusted | 0.77 | 0.79 | 0.80 | 0.83 | <0.0001 |
MV-adjusted | 0.78 | 0.79 | 0.80 | 0.81 | 0.01 | |
RWT | Age-adjusted | 0.25 | 0.26 | 0.26 | 0.27 | 0.0009 |
MV-adjusted | 0.25 | 0.26 | 0.26 | 0.26 | 0.16 | |
CO, L/min | Age-adjusted | 4.6 | 4.6 | 4.9 | 5.2 | <0.0001 |
MV-adjusted | 4.9 | 4.7 | 4.9 | 4.8 | 0.42 | |
LVEF (%) | Age-adjusted | 68 | 69 | 69 | 69 | 0.03 |
MV-adjusted | 68 | 69 | 69 | 69 | 0.33 |
Cells present mean values of LV measures;
p-value for linear trend;
range of HOMA-IR for the respective quartile.
MV-adjusted = multivariable-adjusted; MV model adjusted for age, BMI, systolic blood pressure, cardioactive drug therapy and smoking status.